Transcriptomic and Proteomic Profiling Shows Dysregulated Immune and Metabolic Pathways in Arrhythmogenic Cardiomyopathy
ESC Heart Failure · 2025
DOI: 10.1002/ehf2.70013 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2025. Verfasst von Deniz Akdis und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Proteomics, Transcriptome, Gene Expression Profiling, Arrhythmogenic Right Ventricular Dysplasia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Georg und Bertha Schwyzer-Winiker-Stiftung, Baugarten Stiftung, Stiftung Max und Sophielène Iten-Kohaut.
Abstract (Originalsprache)
Aims
Arrhythmogenic cardiomyopathy (ACM) is a hereditary heart disease characterized by fibrofatty myocardial replacement and a predisposition to malignant ventricular arrhythmias. The underlying pathomechanisms remain incompletely understood, and specific disease markers are sparse. This study aimed to characterize the myocardial transcriptome and proteome in ACM patients and assess whether key identified molecules were also detectable in plasma and tissue samples. Methods and results Myocardial tissues were obtained from ACM and dilated cardiomyopathy (DCM) patients as well as healthy controls (n = 10/group). Transcriptomic profiling was performed by RNA sequencing and proteomic profiling by label-free liquid chromatography–tandem mass spectrometry. Differential expression and pathway enrichment analyses were performed to identify key biological processes. Selected targets were validated by tissue immunofluorescence and plasma ELISA. Transcriptomic analysis revealed 3030 dysregulated mRNAs in ACM versus healthy controls and 120 versus DCM. Enriched clusters in ACM versus healthy controls were related to immune activation, inflammation, extracellular matrix remodelling and mitochondrial stress; redox and metabolic processes, cell junction regulation and immune responses were enriched clusters in ACM versus DCM. Proteomics identified 206 and 65 differentially expressed proteins, respectively. Three novel proteins, UCHL1, OCIAD1 and desmoyokin, were consistently up-regulated at transcript and protein levels. The latter two were confirmed in myocardial tissue staining and showed elevated plasma levels in ACM compared with DCM and controls.
Conclusion
This integrated transcriptomic and proteomic study of myocardial tissue and plasma from patients with ACM compared with those with DCM and healthy controls, identified key dysregulated pathways, involving immune response, inflammation and oxidative and mitochondrial stress. Desmoyokin and OCIAD1, in particular, may represent specific candidate biomarkers for ACM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
- Department of Nephrology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
- Functional Genomics Center Zurich, University of Zurich/ETH Zurich, Zurich, Switzerland.
- Erich and Hanna Klessmann Institute for Cardiovascular Research and Development, Heart and Diabetes Centre NRW, University Hospital of the Ruhr-University, Bad Oeynhausen, Germany.
- Institute of Pathology, Cantonal Hospital Winterthur, Winterthur, Switzerland.
- Center for Translational and Experimental Cardiology (CTEC), University of Zurich, Zurich, Switzerland.
Förderung
- Georg und Bertha Schwyzer-Winiker-Stiftung
- Baugarten Stiftung
- Stiftung Max und Sophielène Iten-Kohaut
- National Science Foundation
- Schweizerische Herzstiftung
- USZ Foundation
- ETH Personalized Medicine Program
Zitieren
APA
Akdis, D., Weidmann, L., Nanni, P., Gaertner, A., Milting, H., Bode, P., Brunckhorst, C., Chen, L., Tanner, F. C., Ruschitzka, F., Saguner, A. M., & Duru, F. (2025). Transcriptomic and Proteomic Profiling Shows Dysregulated Immune and Metabolic Pathways in Arrhythmogenic Cardiomyopathy. ESC Heart Failure. https://doi.org/10.1002/ehf2.70013
Vancouver
Akdis D, Weidmann L, Nanni P, Gaertner A, Milting H, Bode P, et al. Transcriptomic and Proteomic Profiling Shows Dysregulated Immune and Metabolic Pathways in Arrhythmogenic Cardiomyopathy. ESC Heart Failure. 2025. doi:10.1002/ehf2.70013
BibTeX
@article{Akdis2025,
author = {Akdis, Deniz and Weidmann, Lukas and Nanni, Paolo and Gaertner, Anna and Milting, Hendrik and Bode, Peter and Brunckhorst, Corinna and Chen, Liang and Tanner, Felix C and Ruschitzka, Frank and Saguner, Ardan M and Duru, Firat},
title = {Transcriptomic and Proteomic Profiling Shows Dysregulated Immune and Metabolic Pathways in Arrhythmogenic Cardiomyopathy},
journal = {ESC Heart Failure},
year = {2025},
doi = {10.1002/ehf2.70013}
}
EUVIMED